Literature DB >> 19306352

Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.

Marta Lionetti1, Luca Agnelli, Laura Mosca, Sonia Fabris, Adrian Andronache, Katia Todoerti, Domenica Ronchetti, Giorgio Lambertenghi Deliliers, Antonino Neri.   

Abstract

It is thought that altered microRNA (miRNA) expression due to various mechanisms plays a critical role in the pathogenesis of most human cancers. Notably, about half of the known miRNAs are intragenic and frequently coexpressed with their host genes. To date there is little evidence concerning miRNA expression in multiple myeloma (MM). In an attempt to provide insights into miRNA deregulation in MM, we profiled global miRNA expression in a panel of molecularly well-characterized human myeloma cell lines (HMCLs) using high-resolution microarrays, and then used integrative analyses to identify altered patterns correlated with DNA copy number (CN) or gene expression profiles. We identified 16 miRNAs mapped to chromosomal regions frequently involved in numerical imbalances in MM, whose expression significantly correlated with the CN of the corresponding miRNA genes; among these, miR-22 expression was also affected by chromosome arm 17p loss in a representative panel of primary MM tumors. The expression of 32 intronic miRNAs significantly correlated with that of their host transcripts, some of which were highly deregulated in MM patients. The expression of some of the miRNAs was validated by quantitative RT-PCR. Finally, a number of the identified miRNAs have previously been reported to play important roles in tumorigenesis. Overall, our data highlight that genomic alterations may significantly affect miRNA expression in HMCLs and demonstrate a frequent coexpression of intronic miRNAs with their host genes that may have a pathogenetic relevance in plasma cell transformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19306352     DOI: 10.1002/gcc.20660

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  30 in total

1.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

2.  High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

Authors:  Yiming Zhou; Lijuan Chen; Bart Barlogie; Owen Stephens; Xiaosong Wu; David R Williams; Marie-Astrid Cartron; Frits van Rhee; Bijay Nair; Sarah Waheed; Mauricio Pineda-Roman; Yazan Alsayed; Elias Anaissie; John D Shaughnessy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

3.  Downregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression.

Authors:  Lei Zhang; Lin Zhou; Meng Shi; Yong Kuang; Lei Fang
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

4.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.

Authors:  Ankur K Nagaraja; Chad J Creighton; Zhifeng Yu; Huifeng Zhu; Preethi H Gunaratne; Jeffrey G Reid; Emuejevoke Olokpa; Hiroaki Itamochi; Naoto T Ueno; Shannon M Hawkins; Matthew L Anderson; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2010-01-15

Review 5.  An integrative paradigm to impart quality to correlative science.

Authors:  Michael Kalos
Journal:  J Transl Med       Date:  2010-03-16       Impact factor: 5.531

6.  microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.

Authors:  J Zhang; Y Yang; T Yang; Y Liu; A Li; S Fu; M Wu; Z Pan; W Zhou
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

7.  RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.

Authors:  Ying Hu; Samuel W French; Thinh Chau; Hui-Xin Liu; Lili Sheng; Fang Wei; Jesse Stondell; Juan C Garcia; Yanlei Du; Christopher L Bowlus; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-09-25       Impact factor: 5.191

8.  Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.

Authors:  Jian-Jun Zhao; Zhang-Bo Chu; Yu Hu; Jianhong Lin; Zhongqiu Wang; Meng Jiang; Ming Chen; Xujun Wang; Yue Kang; Yangsheng Zhou; Triona Ni Chonghaile; Melanie E Johncilla; Yu-Tzu Tai; Jin Q Cheng; Antony Letai; Nikhil C Munshi; Kenneth C Anderson; Ruben D Carrasco
Journal:  Cancer Res       Date:  2015-08-06       Impact factor: 12.701

9.  Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.

Authors:  Liang Zhou; Zuwei Li; Xiang Pan; Yulin Lai; Jing Quan; Liwen Zhao; Jinling Xu; Weijie Xu; Xin Guan; Hang Li; Shangqi Yang; Yaoting Gui; Yongqing Lai
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 10.  Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.

Authors:  Raj Chari; Kelsie L Thu; Ian M Wilson; William W Lockwood; Kim M Lonergan; Bradley P Coe; Chad A Malloff; Adi F Gazdar; Stephen Lam; Cathie Garnis; Calum E MacAulay; Carlos E Alvarez; Wan L Lam
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.